Quick Answer
Zomedica Corp. reported Total Assets of $127.04 million for the year ending 2025.
- Zomedica Corp. showed a decrease of -38.7% in Total Assets from 2024 to 2025.
- This data is from Zomedica Corp.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $4.90 million | Q2 2018: $6.42 million | Q3 2018: $4.19 million | Q1 2019: $5.89 million | Q2 2019: $9.48 million | Q3 2019: $6.61 million | Q1 2020: $5.03 million | Q2 2020: $32.76 million | Q3 2020: $56.60 million | Q1 2021: $280.47 million | Q2 2021: $280.35 million | Q3 2021: $277.50 million | Q1 2022: $277.99 million | Q2 2022: $275.48 million | Q3 2022: $282.30 million | Q1 2023: $279.60 million | Q2 2023: $274.78 million | Q3 2023: $275.05 million | Q1 2024: $243.70 million | Q2 2024: $219.88 million | Q3 2024: $214.12 million | Q1 2025: $142.99 million | Q2 2025: $136.47 million | Q3 2025: $130.91 million.
- Over the full 10 years of available data (2016 to 2025), Zomedica Corp.'s Total Assets has grown by 2,676.5%.
- Historical annual values: Fiscal year 2025: $127.04 million | Fiscal year 2024: $207.36 million | Fiscal year 2023: $253.20 million | Fiscal year 2022: $279.61 million | Fiscal year 2021: $280.40 million | Fiscal year 2020: $66.14 million | Fiscal year 2019: $4.18 million | Fiscal year 2018: $6.03 million | Fiscal year 2017: $5.22 million | Fiscal year 2016: $4.58 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: